Literature DB >> 25949066

Staphylococcal small colony variants from a libyan hospital.

Mohamed O Ahmed1, Ezzeddin Sh Aghila2, Asma K Elramalli3, Mohamed S Agdih2.   

Abstract

Entities:  

Year:  2015        PMID: 25949066      PMCID: PMC4411817          DOI: 10.4103/0974-2727.154804

Source DB:  PubMed          Journal:  J Lab Physicians        ISSN: 0974-2727


× No keyword cloud information.
Sir, Bacterial small colony variants (SCVs) are natural subpopulation developed by many bacterial species in response to several factors, including antibiotic use and environmental stressors.[12] These variants have been increasingly reported in various clinical samples, representing either persistent colonization, fatal infection cases in humans or cases related to antibiotic use in humans and animals.[134] Bacterial SCVs, particularly of staphylococcal species, are widely reported and characterized by small colonial growth and reduced to variable biochemical and virulence traits at genera and species level.[1] These properties can significantly complicate the laboratory and diagnostic testing and may result in therapeutic failures. A bacterial cultures of Gram-positive cocci (n = 5) of clinical sources from a hospital in Tripoli that developed subpopulation colonial growth, and atypical phenotypic characteristics were investigated for SVCs [Figure 1]. These were identified as Staphylococcus aureus (n = 2), Staphylococcus epidermidis (n = 1) and Staphylococcus hominis (n = 2) using the Vitek automated identification system using the typical growing colonies (wild type [WT]).
Figure 1

Small colony variants growth and characterization on blood agar medium. (a and b) Staphylococci growth (SVCs and wild-type colonies)

Small colony variants growth and characterization on blood agar medium. (a and b) Staphylococci growth (SVCs and wild-type colonies) The isolates were grown overnight on sheep blood agar (Oxoid) supplemented with 5% NaCl and mannitol salt agar and incubated at 35°C for 48–72 h. Single small colonies from each culture were further tested and characterized as SCVs if they showed typical pinpoint growth (1/10 of typical growing colony) and reduced/variable hemolysis and pigmentation properties, following the recommendations of recent reports.[56] SCVs were continuously sub-cultured on sheep blood agar for 7 consecutive days in order to observe the density of SCVs and the ability to revert into WT colonies. All isolates showed typical SCVs and variable phenotypic properties. SCV cultures showed reduced density after 5 days of sub-culturing. Staphylococcal SCVs have been widely reported from different clinical sources and largely associated with antibiotic therapies.[17] The slow growth property and other variable phenotypic characteristics are associated with variable susceptibility to antimicrobial agents, which is sometimes transient, compromising the accurately of the laboratory testing.[12] The intracellular growth characteristics and reversion ability of SCVs into its WT are another laboratory complications and appear to occur regardless the selective pressures known to induce SCV formation.[689] The small studied isolates were from a hospital environment, and such stressful environment has likely contributed to the formation of SVCs.[6] Bacterial SCVs are a laboratory challenge, largely associated with antimicrobial therapies and limit the diagnostic and treatment options.[17] Identification and characterization of SCVs depend largely on phenotypic and morphologic characterization using recommended laboratory procedures.[56] The information in this report should serve to alert hospital management teams and laboratory professionals of the difficulties associated with the identification of such variants and the high risk of misdiagnosis mainly in developing countries.
  9 in total

1.  Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients.

Authors:  S Yagci; G Hascelik; D Dogru; U Ozcelik; B Sener
Journal:  Clin Microbiol Infect       Date:  2012-01-27       Impact factor: 8.067

Review 2.  Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections.

Authors:  Richard A Proctor; Christof von Eiff; Barbara C Kahl; Karsten Becker; Peter McNamara; Mathias Herrmann; Georg Peters
Journal:  Nat Rev Microbiol       Date:  2006-04       Impact factor: 60.633

Review 3.  Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians.

Authors:  Christof von Eiff
Journal:  Int J Antimicrob Agents       Date:  2008-01-03       Impact factor: 5.283

4.  Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence.

Authors:  Lorena Tuchscherr; Vanessa Heitmann; Muzaffar Hussain; Dorothee Viemann; Johannes Roth; Christof von Eiff; Georg Peters; Karsten Becker; Bettina Löffler
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 5.  Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data.

Authors:  Laetitia G Garcia; Sandrine Lemaire; Barbara C Kahl; Karsten Becker; Richard A Proctor; Olivier Denis; Paul M Tulkens; Françoise Van Bambeke
Journal:  J Antimicrob Chemother       Date:  2013-03-13       Impact factor: 5.790

Review 6.  Small colony variants (SCVs) of Staphylococcus aureus--a bacterial survival strategy.

Authors:  Barbara C Kahl
Journal:  Infect Genet Evol       Date:  2013-05-27       Impact factor: 3.342

7.  Staphylococcus aureus as an intracellular pathogen: the role of small colony variants.

Authors:  Parham Sendi; Richard A Proctor
Journal:  Trends Microbiol       Date:  2009-01-21       Impact factor: 17.079

8.  Fatal case due to methicillin-resistant Staphylococcus aureus small colony variants in an AIDS patient.

Authors:  H Seifert; C von Eiff; G Fätkenheuer
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

9.  Phenotypic variants of staphylococci and their underlying population distributions following exposure to stress.

Authors:  Laura A Onyango; R Hugh Dunstan; Timothy K Roberts; Margaret M Macdonald; Johan Gottfries
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.